Njm. Birdsall et al., Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: Functional studies, MOLEC PHARM, 55(4), 1999, pp. 778-786
In radioligand binding studies, it has been reported that brucine, N-chloro
methyl brucine, and brucine N-oxide increased the affinity of acetylcholine
for M-1, M-3, and M-4 muscarinic receptors, respectively, in a manner cons
istent with the predictions of the ternary complex allosteric model. We now
demonstrate an equivalent ability of these three allosteric agents to modu
late the actions of acetylcholine in functional studies in membranes and in
whole cells. The enhancing actions of brucine and brucine N-oxide on acety
lcholine (ACh) potency at M-1 and M-4 receptors respectively have been conf
irmed in guanosine-5'-O-(3-[S-35]thio)triphosphate, GTPase, cAMP, and intra
cellular Ca2+ mobilization assays of function. In general, neither the basa
l nor the maximally stimulated response to ACh is affected. The subtype-sel
ective allosteric effects of N-chloromethyl brucine on M-2 and M-3 receptor
s were shown to be qualitatively and quantitatively the same in guanosine-5
'-O-(3-S-35]thio)triphosphate functional assays, in terms of both its affin
ity and cooperativity with ACh, as those found in binding assays. Neutral c
ooperativity of N-chloromethyl brucine with ACh on M-4 receptor function wa
s also observed, thereby demonstrating its "absolute subtype selectivity":
a lack of action at any concentration at M-4 receptors and an action at M-2
and M-3 receptors. The enhancing action of N-chloromethyl brucine on neuro
genically released ACh binding at M-3 receptors was also detected in whole
tissue as an increased contraction of the isolated guinea pig ileum to subm
aximal electrical stimulation. In conclusion, these functional studies conf
irm that brucine analogs are allosteric enhancers of ACh affinity at certai
n muscarinic receptor subtypes.